Standard Practice for Assessment of Hemolytic Properties of Materials


Importancia y uso:

5.1 The presence of hemolytic material in contact with the blood may cause loss of, or damage to, red blood cells and may produce increased levels of free plasma hemoglobin capable of inducing toxic effects or other effects which may stress the kidneys or other organs.

5.2 This practice may not be predictive of events occurring during all types of implant applications. The user is cautioned to consider the appropriateness of the method in view of the materials being tested, their potential applications, and the recommendations contained in Practice F748.

Subcomité:

F04.16

Referida por:

F2064-17, F2224-09R20, F2565-21, F0451-21, F2848-21, F2901-19, F0648-21, F2103-18, F0748-25, F2347-24, E2524-22, F2695-12R25, F2759-19, E3219-25

Volúmen:

13.01

Número ICS:

11.100 (Laboratory medicine)

Palabras clave:

biocompatibility; blood compatibility; direct contact; extract; hemoglobin; hemolysis testing;

$ 1,194

Agregar al carrito

Norma
F756

Versión
17(2025)

Estatus
Active

Clasificación
Practice

Fecha aprobación
2025-08-01